Form 4 for LUNG Pulmonx Corp
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-01 | LUNG | French Glendon E. III | Pres AND CEO, Dir | S - Sale | $9.06 | -6,954 | 1.12M | -0.6% | -$63.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | S | D | 3,947 | $9.06 | 1,116,758 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-01 | S | D | 1,189 | $9.06 | 1,122,523 | D | — | — | (F2) Includes 2,368 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2024. |
| 3 | Common | Common Stock | 2024-03-01 | S | D | 1,818 | $9.06 | 1,120,705 | D | — | — |